Newsletter Subject

Alzheimer's Slowed by Intensive Lifestyle Changes

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Jun 11, 2024 10:47 PM

Email Preheader Text

Daily Headlines Tuesday, June 11, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Tuesday, June 11, 2024 Today's Top Stories for {NAME} [NEUROLOGY]( [Alzheimer's Slowed by Intensive Lifestyle Changes]( [INFECTIOUS DISEASE]( [New Long COVID Definition Proposed by National Academies]( [ONCOLOGY/HEMATOLOGY]( [Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Empowering Patients in Their Beta Thalassemia Care: Strategies for Effective Transitions of Care and Shared Decision-Making]( [MEETING COVERAGE]( [Testosterone Prodrug Improves Muscle Mass, Encephalopathy in Men With Cirrhosis]( [MEETING COVERAGE]( [Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patients]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [OB/GYN]( [Trump Tells Group That Wants to Ban All Abortions to Stand Up for 'Innocent Life']( CME SPOTLIGHT [Empowering Historically Underrepresented Patients: Overcoming Healthcare Disparities in Multiple Myeloma]( [PERSPECTIVES]( [Sounding the Alarm: The Silent Epidemic of Suicide Among U.S. Veterans]( [NEUROLOGY]( [Tetanus Shots and Parkinson's; Predicting Future Dementia; Cognition-Depression Link]( [CARDIOLOGY]( [Heat Exposure & Heart Stress; 2-Hour POC Troponin Assay; Colchicine After Stroke?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Expert Insight Into von Hippel-Lindau (VHL) Disease: From Symptoms and Diagnosis to Cutting-Edge Therapies and Adverse Event Management]( [INFECTIOUS DISEASE]( [With Bird Flu Tests Hard to Get, How Will We Know When to Sound a Pandemic Alarm?]( [PULMONOLOGY]( [Repeat Anesthesia in Kids With Cystic Fibrosis Didn't Lead to Neurobehavioral Harms]( [ENDOCRINOLOGY]( [Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing]( CME SPOTLIGHT [Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes]( [PERSPECTIVES]( [Was the FDA Panel Right to Recommend Against MDMA Approval?]( [MEETING COVERAGE]( [AMA Passes Resolution Calling for Peace in Israel and Palestine]( [GASTROENTEROLOGY]( [Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval]( CME SPOTLIGHT [Updates to AML Classification and Treatment Paradigm]( [PUBLIC HEALTH & POLICY]( [What to Know About FDA's Warning on Paralytic Shellfish Poisonings]( [PEDIATRICS]( [Google Translate, ChatGPT Good Enough for Translating Kids' Discharge Instructions?]( CME SPOTLIGHT [Positioning CAR T-Cell Therapy in the CLL Treatment Landscape]( Industry Clinic AD INSIGHTS [What Will It Take to Deliver Both Health & Care in Oncology?]( # Weekly Survey [Fauci: Love Him or Hate Him?]( Former NIAID director Anthony Fauci, MD, has proven to be a polarizing figure; this week he [faced tough questions from lawmakers]( over his role in approving coronavirus-related research grants[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-06-11&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.